Anti-Human CD55 (JS11)

CD55 Monoclonal Antibody for FC
Cat No. 65271-1-Ig

产品说明书

CloneNo. JS11

宿主/亚型

Mouse / IgG1

种属反应性

human

应用

FC

Complement decay-accelerating factor, CR, CROM, DAF, JS11

缓冲液配方:  PBS and Azide
PBS and Azide
规格价格库存


经过测试的应用

Positive FC detected inhuman PBMCs

推荐稀释比

应用推荐稀释比
Flow Cytometry (FC)FC : 0.2 ug per 10^6 cells in 100 μl suspension
This reagent has been tested for flow cytometric analysis. It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

产品信息

65271-1-Ig targets CD55 in FC applications and shows reactivity with human samples.

经测试应用 FC Application Description
经测试反应性 human
免疫原 N/A 种属同源性预测
宿主/亚型 Mouse / IgG1
抗体类别 Monoclonal
产品类型 Antibody
全称 CD55 molecule, decay accelerating factor for complement (Cromer blood group)
别名 Complement decay-accelerating factor, CR, CROM, DAF, JS11
计算分子量 41 kDa
GenBank蛋白编号BC001288
基因名称 CD55
Gene ID (NCBI) 1604
RRIDAB_2935140
偶联类型 Unconjugated
形式Liquid
纯化方式Affinity purification
UNIPROT IDP08174
储存缓冲液 PBS with 0.09% sodium azide, pH 7.3.
储存条件Store at 2-8°C. Stable for one year after shipment.

背景介绍

CD55, also known as DAF, is a glycosylphosphatidylinositol (GPI)-anchored surface glycoprotein that is widely distributed on blood, stroma, epithelial, and endothelial cells (PMID: 7517044; 29503741). It can also exist as a soluble form in plasma, urine, saliva, tears, and synovial fluids (PMID: 29503741). CD55 is a complement regulatory protein (PMID: 2469439; 7517044). It inhibits formation of the C3 convertases through binding to C3b and C4b. It also binds the alternate pathway convertase C3bBb, the classical pathway convertase and C4b2a to accelerate their decay (PMID: 17289551). CD55 also serves as a receptor for coxsackieviruses B1, B3, and B5 and several enteroviruses (PMID: 7538177; 7517044).

实验方案

Product Specific Protocols
FC protocol for CD55 antibody 65271-1-IgDownload protocol
Standard Protocols
Click here to view our Standard Protocols
Loading...